Skip to main content
Top
Published in: Inflammation 2/2013

01-04-2013

Proliferation and Apoptosis of Peripheral Blood Mononuclear Cells in Patients with Oral Lichen Planus

Authors: Jing Shan, Jiang-Min Ma, Ran Wang, Qing-Lan Liu, Yuan Fan

Published in: Inflammation | Issue 2/2013

Login to get access

Abstract

Oral lichen planus (OLP) is generally accepted to be a T cell-mediated chronic inflammatory disease with an unclear pathogenesis. There have been numerous studies on the proliferation and apoptosis of T cells in situ. In contrast, research on the proliferation and apoptosis of peripheral blood mononuclear cells (PBMCs) in patients with OLP is rare. The aim of the present study was to investigate the proliferation and apoptosis of PBMCs in patients with OLP. PBMCs were isolated from 20 patients with reticular OLP, 20 patients with atrophic-erosive OLP, and 20 healthy volunteers. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2,5-tetrazolium bromide assays were performed to investigate the proliferation of PBMCs, and caspase-3 colorimetric assays were performed to investigate the apoptosis of PBMCs. The proliferation rate of PBMCs in atrophic-erosive OLP subjects was significantly higher than that in both healthy (P < 0.05) and reticular OLP (P < 0.05) subjects. In contrast, the proliferation rate of PBMCs in reticular OLP subjects was significantly lower than that in healthy subjects (P < 0.05). The apoptosis rates of PBMCs in OLP subjects (P < 0.05) and atrophic-erosive OLP subjects (P < 0.05) were significantly lower than the apoptosis rate in the healthy group. Our findings reinforce the view that T cell-mediated immune responses play a critical role in the pathogenesis of OLP. It can reasonably be concluded that these abnormalities are linked to the presence of inflammatory infiltrates.
Literature
1.
go back to reference McCartan, B.E., and C.M. Healy. 2008. The reported prevalence of oral lichen planus: A review and critique. Journal of Oral Pathology & Medicine 37: 447–453.CrossRef McCartan, B.E., and C.M. Healy. 2008. The reported prevalence of oral lichen planus: A review and critique. Journal of Oral Pathology & Medicine 37: 447–453.CrossRef
2.
go back to reference Usatine, R.P., and M. Tinitigan. 2011. Diagnosis and treatment of lichen planus. American Family Physician 84: 53–60.PubMed Usatine, R.P., and M. Tinitigan. 2011. Diagnosis and treatment of lichen planus. American Family Physician 84: 53–60.PubMed
3.
go back to reference van der Waal, I. 2009. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncology 45: 317–323.PubMedCrossRef van der Waal, I. 2009. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncology 45: 317–323.PubMedCrossRef
4.
go back to reference Farhi, D., and N. Dupin. 2010. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: Facts and controversies. Clinics in Dermatology 28: 100–108.PubMedCrossRef Farhi, D., and N. Dupin. 2010. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: Facts and controversies. Clinics in Dermatology 28: 100–108.PubMedCrossRef
5.
go back to reference Rodriguez-Nunez, I., A. Blanco-Carrion, A.G. Garcia, and J.G. Rey. 2001. Peripheral T-cell subsets in patients with reticular and atrophic-erosive oral lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 91: 180–188.PubMedCrossRef Rodriguez-Nunez, I., A. Blanco-Carrion, A.G. Garcia, and J.G. Rey. 2001. Peripheral T-cell subsets in patients with reticular and atrophic-erosive oral lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 91: 180–188.PubMedCrossRef
6.
go back to reference Roopashree, M.R., R.V. Gondhalekar, M.C. Shashikanth, J. George, S.H. Thippeswamy, and A. Shukla. 2010. Pathogenesis of oral lichen planus—A review. Journal of Oral Pathology & Medicine 39: 729–734.CrossRef Roopashree, M.R., R.V. Gondhalekar, M.C. Shashikanth, J. George, S.H. Thippeswamy, and A. Shukla. 2010. Pathogenesis of oral lichen planus—A review. Journal of Oral Pathology & Medicine 39: 729–734.CrossRef
7.
go back to reference Charazinska-Carewicz, K., E. Ganowicz, M. Krol, and R. Gorska. 2008. Assessment of the peripheral immunocompetent cells in patients with reticular and atrophic-erosive lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 105: 202–205.PubMedCrossRef Charazinska-Carewicz, K., E. Ganowicz, M. Krol, and R. Gorska. 2008. Assessment of the peripheral immunocompetent cells in patients with reticular and atrophic-erosive lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 105: 202–205.PubMedCrossRef
8.
go back to reference Carrozzo, M., R. Broccoletti, M. Carbone, S. Gandolfo, P. Garzino, and G. Cascio. 1996. Phenotypic analysis of peripheral blood cell immunity in Italian patients with different varieties of oral lichen planus. Bulletin du Groupement International Pour la Recherche Scientifique En Stomatologie et Odontologie 39: 33–38. Carrozzo, M., R. Broccoletti, M. Carbone, S. Gandolfo, P. Garzino, and G. Cascio. 1996. Phenotypic analysis of peripheral blood cell immunity in Italian patients with different varieties of oral lichen planus. Bulletin du Groupement International Pour la Recherche Scientifique En Stomatologie et Odontologie 39: 33–38.
9.
go back to reference Karagouni, E.E., E.N. Dotsika, and A. Sklavounou. 1994. Alteration in peripheral blood mononuclear cell function and serum cytokines in oral lichen planus. Journal of Oral Pathology & Medicine 23: 28–35.CrossRef Karagouni, E.E., E.N. Dotsika, and A. Sklavounou. 1994. Alteration in peripheral blood mononuclear cell function and serum cytokines in oral lichen planus. Journal of Oral Pathology & Medicine 23: 28–35.CrossRef
10.
go back to reference Gotoh, A., Y. Hamada, N. Shiobara, K. Kumagai, K. Seto, T. Horikawa, and R. Suzuki. 2008. Skew in T cell receptor usage with polyclonal expansion in lesions of oral lichen planus without hepatitis C virus infection. Clinical & Experimental Immunology 154: 192–201.CrossRef Gotoh, A., Y. Hamada, N. Shiobara, K. Kumagai, K. Seto, T. Horikawa, and R. Suzuki. 2008. Skew in T cell receptor usage with polyclonal expansion in lesions of oral lichen planus without hepatitis C virus infection. Clinical & Experimental Immunology 154: 192–201.CrossRef
11.
go back to reference Kalogerakou, F., E. Albanidou-Farmaki, A.K. Markopoulos, and D.Z. Antoniades. 2008. Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus. Hippokratia 12: 230–235.PubMed Kalogerakou, F., E. Albanidou-Farmaki, A.K. Markopoulos, and D.Z. Antoniades. 2008. Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus. Hippokratia 12: 230–235.PubMed
12.
go back to reference Lu, R., G. Zhou, G. Du, X. Xu, J. Yang, and J. Hu. 2011. Expression of T-bet and GATA-3 in peripheral blood mononuclear cells of patients with oral lichen planus. Archives of Oral Biology 56: 499–505.PubMedCrossRef Lu, R., G. Zhou, G. Du, X. Xu, J. Yang, and J. Hu. 2011. Expression of T-bet and GATA-3 in peripheral blood mononuclear cells of patients with oral lichen planus. Archives of Oral Biology 56: 499–505.PubMedCrossRef
13.
14.
go back to reference Chen, W. 2007. Medical immunology, 32. Beijing: People’s Medical Publishing House. Chen, W. 2007. Medical immunology, 32. Beijing: People’s Medical Publishing House.
15.
go back to reference Dorn, A.D., W.R. Waters, V.M. Byers, B.A. Pesch, and M.J. Wannemuehler. 2002. Characterization of mitogen-stimulated porcine lymphocytes using a stable fluorescent dye (PKH2) and multicolor flow cytometry. Veterinary Immunology and Immunopathology 87: 1–10.PubMedCrossRef Dorn, A.D., W.R. Waters, V.M. Byers, B.A. Pesch, and M.J. Wannemuehler. 2002. Characterization of mitogen-stimulated porcine lymphocytes using a stable fluorescent dye (PKH2) and multicolor flow cytometry. Veterinary Immunology and Immunopathology 87: 1–10.PubMedCrossRef
16.
go back to reference Quade, M.J., and J.A. Roth. 1999. Dual-color flow cytometric analysis of phenotype, activation marker expression, and proliferation of mitogen-stimulated bovine lymphocyte subsets. Veterinary Immunology and Immunopathology 67: 33–45.PubMedCrossRef Quade, M.J., and J.A. Roth. 1999. Dual-color flow cytometric analysis of phenotype, activation marker expression, and proliferation of mitogen-stimulated bovine lymphocyte subsets. Veterinary Immunology and Immunopathology 67: 33–45.PubMedCrossRef
17.
go back to reference Tian, X., Y. Zhao, and Z.G. Li. 2009. T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis. Zhonghua Yi Xue Za Zhi 89: 673–676.PubMed Tian, X., Y. Zhao, and Z.G. Li. 2009. T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis. Zhonghua Yi Xue Za Zhi 89: 673–676.PubMed
18.
go back to reference Hainaut, M., V. Verscheure, M. Ducarme, L. Schandene, J. Levy, and F. Mascart. 2011. Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: Is immune restoration by highly active anti-retroviral therapy comparable to non-progression? Clinical & Experimental Immunology 165: 77–84.CrossRef Hainaut, M., V. Verscheure, M. Ducarme, L. Schandene, J. Levy, and F. Mascart. 2011. Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: Is immune restoration by highly active anti-retroviral therapy comparable to non-progression? Clinical & Experimental Immunology 165: 77–84.CrossRef
19.
go back to reference Al-Hashimi, I., M. Schifter, P.B. Lockhart, D. Wray, M. Brennan, C.A. Migliorati, T. Axell, A.J. Bruce, W. Carpenter, E. Eisenberg, J.B. Epstein, P. Holmstrup, M. Jontell, F. Lozada-Nur, R. Nair, B. Silverman, K. Thongprasom, M. Thornhill, S. Warnakulasuriya, and I. van der Waal. 2007. Oral lichen planus and oral lichenoid lesions: Diagnostic and therapeutic considerations. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 103: S25.e21–S25.e12.CrossRef Al-Hashimi, I., M. Schifter, P.B. Lockhart, D. Wray, M. Brennan, C.A. Migliorati, T. Axell, A.J. Bruce, W. Carpenter, E. Eisenberg, J.B. Epstein, P. Holmstrup, M. Jontell, F. Lozada-Nur, R. Nair, B. Silverman, K. Thongprasom, M. Thornhill, S. Warnakulasuriya, and I. van der Waal. 2007. Oral lichen planus and oral lichenoid lesions: Diagnostic and therapeutic considerations. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 103: S25.e21–S25.e12.CrossRef
20.
go back to reference Lavanya, N., P. Jayanthi, U.K. Rao, and K. Ranganathan. 2011. Oral lichen planus: An update on pathogenesis and treatment. Journal of Oral and Maxillofacial Pathology 15: 127–132.PubMedCrossRef Lavanya, N., P. Jayanthi, U.K. Rao, and K. Ranganathan. 2011. Oral lichen planus: An update on pathogenesis and treatment. Journal of Oral and Maxillofacial Pathology 15: 127–132.PubMedCrossRef
21.
go back to reference Yamamoto, T., K. Yoneda, E. Ueta, and T. Osaki. 1990. Cellular immunosuppression in oral lichen planus. Journal of Oral Pathology & Medicine 19: 464–470.CrossRef Yamamoto, T., K. Yoneda, E. Ueta, and T. Osaki. 1990. Cellular immunosuppression in oral lichen planus. Journal of Oral Pathology & Medicine 19: 464–470.CrossRef
22.
go back to reference Konttinen, Y.T., P. Jungell, V. Bergroth, G. Hampf, P. Kemppinen, and M. Malmstrom. 1989. PHA stimulation of peripheral blood lymphocytes in oral lichen planus. Abnormality localized between interleukin-2 receptor ligand formation and gamma-interferon secretion. Journal of clinical & laborartory immunology 28: 33–37. Konttinen, Y.T., P. Jungell, V. Bergroth, G. Hampf, P. Kemppinen, and M. Malmstrom. 1989. PHA stimulation of peripheral blood lymphocytes in oral lichen planus. Abnormality localized between interleukin-2 receptor ligand formation and gamma-interferon secretion. Journal of clinical & laborartory immunology 28: 33–37.
23.
go back to reference Karatsaidis, A., O. Schreurs, K. Helgeland, T. Axell, and K. Schenck. 2003. Erythematous and reticular forms of oral lichen planus and oral lichenoid reactions differ in pathological features related to disease activity. Journal of Oral Pathology & Medicine 32: 275–281.CrossRef Karatsaidis, A., O. Schreurs, K. Helgeland, T. Axell, and K. Schenck. 2003. Erythematous and reticular forms of oral lichen planus and oral lichenoid reactions differ in pathological features related to disease activity. Journal of Oral Pathology & Medicine 32: 275–281.CrossRef
24.
go back to reference Sousa, F.A., and L.E. Rosa. 2008. Oral lichen planus: Clinical and histopathological considerations. Revista Brasileira de Otorrinolaringologia 74: 284–292.PubMedCrossRef Sousa, F.A., and L.E. Rosa. 2008. Oral lichen planus: Clinical and histopathological considerations. Revista Brasileira de Otorrinolaringologia 74: 284–292.PubMedCrossRef
25.
go back to reference Brant, J.M., A.C. Vasconcelos, and L.V. Rodrigues. 2008. Role of apoptosis in erosive and reticular oral lichen planus exhibiting variable epithelial thickness. Brazilian Dental Journal 19: 179–185.PubMedCrossRef Brant, J.M., A.C. Vasconcelos, and L.V. Rodrigues. 2008. Role of apoptosis in erosive and reticular oral lichen planus exhibiting variable epithelial thickness. Brazilian Dental Journal 19: 179–185.PubMedCrossRef
26.
go back to reference Chiappelli, F., M.A. Kung, P. Nguyen, P. Villanueva, E.A. Farhadian, and L.R. Eversole. 1997. Cellular immune correlates of clinical severity in oral lichen planus: Preliminary association with mood states. Oral Diseases 3: 64–70.PubMedCrossRef Chiappelli, F., M.A. Kung, P. Nguyen, P. Villanueva, E.A. Farhadian, and L.R. Eversole. 1997. Cellular immune correlates of clinical severity in oral lichen planus: Preliminary association with mood states. Oral Diseases 3: 64–70.PubMedCrossRef
27.
go back to reference Kabelitz, D., and O. Janssen. 1997. Antigen-induced death of T-lymphocytes. Frontiers in Bioscience 2: d61–d77.PubMed Kabelitz, D., and O. Janssen. 1997. Antigen-induced death of T-lymphocytes. Frontiers in Bioscience 2: d61–d77.PubMed
28.
go back to reference Janssen, O., R. Sanzenbacher, and D. Kabelitz. 2000. Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell and Tissue Research 301: 85–99.PubMedCrossRef Janssen, O., R. Sanzenbacher, and D. Kabelitz. 2000. Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell and Tissue Research 301: 85–99.PubMedCrossRef
29.
go back to reference Chowdhury, I., B. Tharakan, and G.K. Bhat. 2008. Caspases—An update. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 151: 10–27.CrossRef Chowdhury, I., B. Tharakan, and G.K. Bhat. 2008. Caspases—An update. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 151: 10–27.CrossRef
30.
go back to reference Fan, T.J., L.H. Han, R.S. Cong, and J. Liang. 2005. Caspase family proteases and apoptosis. Acta Biochimica et Biophysica Sinica 37: 719–727.PubMedCrossRef Fan, T.J., L.H. Han, R.S. Cong, and J. Liang. 2005. Caspase family proteases and apoptosis. Acta Biochimica et Biophysica Sinica 37: 719–727.PubMedCrossRef
31.
go back to reference Igney, F.H., and P.H. Krammer. 2002. Death and anti-death: Tumour resistance to apoptosis. Nature Reviews Cancer 2: 277–288.PubMedCrossRef Igney, F.H., and P.H. Krammer. 2002. Death and anti-death: Tumour resistance to apoptosis. Nature Reviews Cancer 2: 277–288.PubMedCrossRef
32.
go back to reference Elmore, S. 2007. Apoptosis: A review of programmed cell death. Toxicologic Pathology 35: 495–516.PubMedCrossRef Elmore, S. 2007. Apoptosis: A review of programmed cell death. Toxicologic Pathology 35: 495–516.PubMedCrossRef
33.
go back to reference Bascones-Ilundain, C., M.A. Gonzalez-Moles, G. Esparza-Gomez, J.A. Gil-Montoya, and A. Bascones-Martinez. 2006. Importance of apoptotic mechanisms in inflammatory infiltrate of oral lichen planus lesions. Anticancer Research 26: 357–362.PubMed Bascones-Ilundain, C., M.A. Gonzalez-Moles, G. Esparza-Gomez, J.A. Gil-Montoya, and A. Bascones-Martinez. 2006. Importance of apoptotic mechanisms in inflammatory infiltrate of oral lichen planus lesions. Anticancer Research 26: 357–362.PubMed
34.
go back to reference Neppelberg, E., A.C. Johannessen, and R. Jonsson. 2001. Apoptosis in oral lichen planus. European Journal of Oral Sciences 109: 361–364.PubMedCrossRef Neppelberg, E., A.C. Johannessen, and R. Jonsson. 2001. Apoptosis in oral lichen planus. European Journal of Oral Sciences 109: 361–364.PubMedCrossRef
35.
go back to reference Sugerman, P.B., and N.W. Savage. 2002. Oral lichen planus: Causes, diagnosis and management. Australian Dental Journal 47: 290–297.PubMedCrossRef Sugerman, P.B., and N.W. Savage. 2002. Oral lichen planus: Causes, diagnosis and management. Australian Dental Journal 47: 290–297.PubMedCrossRef
36.
go back to reference Sugerman, P.B., K. Satterwhite, and M. Bigby. 2000. Autocytotoxic T-cell clones in lichen planus. British Journal of Dermatology 142: 449–456.PubMedCrossRef Sugerman, P.B., K. Satterwhite, and M. Bigby. 2000. Autocytotoxic T-cell clones in lichen planus. British Journal of Dermatology 142: 449–456.PubMedCrossRef
37.
go back to reference Imanguli, M.M., I. Alevizos, R. Brown, S.Z. Pavletic, and J.C. Atkinson. 2008. Oral graft-versus-host disease. Oral Diseases 14: 396–412.PubMedCrossRef Imanguli, M.M., I. Alevizos, R. Brown, S.Z. Pavletic, and J.C. Atkinson. 2008. Oral graft-versus-host disease. Oral Diseases 14: 396–412.PubMedCrossRef
Metadata
Title
Proliferation and Apoptosis of Peripheral Blood Mononuclear Cells in Patients with Oral Lichen Planus
Authors
Jing Shan
Jiang-Min Ma
Ran Wang
Qing-Lan Liu
Yuan Fan
Publication date
01-04-2013
Publisher
Springer US
Published in
Inflammation / Issue 2/2013
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9561-3

Other articles of this Issue 2/2013

Inflammation 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine